Premium
Secretion of Colony‐Stimulating Factors by Human Monocytes and Bone Marrow Cells After In Vitro Treatment With Biological Response Modifiers
Author(s) -
Schlick E.,
Hartung K.,
Stevenson H.C.,
Chirigos M.A.
Publication year - 1985
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.37.5.615
Subject(s) - myelopoiesis , secretion , biology , granulocyte , in vitro , monocyte , bone marrow , progenitor cell , granulocyte macrophage colony stimulating factor , peripheral blood mononuclear cell , monoclonal antibody , macrophage , colony stimulating factor , immunology , in vivo , antibody , microbiology and biotechnology , haematopoiesis , endocrinology , biochemistry , stem cell
The results of this study indicate that human interferons (hlFNs) may have bimodal effects in vitro on human myelopoiesis. Low concentrations of hlFNα (1–10 U/ml), hlFNβ (1–100 U/ml), and hlFNℽ (1 U/ml) stimulated in vitro increased secretion of colony‐stimulating factors (CSF) by human blood monocytes, which induced growth and differentiation of granulocyte‐macrophage progenitor cells. High concentrations of hlFNsα,β,ℽ (> 100 U/ml), however, had direct antiproliferative effects on granulocyte‐macrophage progenitors. Both effects could be blocked by monoclonal antibodies against hlFNa and hlFNℽ, as well as by heteroantiserum against hlFNβ. Human IFNs did not appear to be involved in mediating the response to the chemically defined biological response modifiers (BRMs) poly ICLC (polyriboinosinic‐polycytidylic acid poly‐L‐lysine) and BM 41.332 (2‐cyano‐1‐[(2‐methoxy‐6‐methyl‐pyridin‐3yl)‐ methyl]‐aziridine), since neutralizing antibodies against the human IFNs (anti‐ IFNα,β,ℽ) did not block the poly ICLC and BM 41.332‐induced secretion of CSF by human blood monocytes. In contrast to hlFNs, poly ICLC and BM 41.332 also stimulated adherent human mononuclear bone marrow cells to secrete CSF, which induced growth and differentiation of nonadherent granulocyte‐ macrophage progenitors. The studies presented here thus support the concept that selected BRMs might be useful to stimulate in vivo secretion of myelo‐poietic growth factors and thereby promote granulocyte and monocyte/macrophage functions.